tiprankstipranks
Trending News
More News >
Argenica Therapeutics Ltd (AU:AGN)
ASX:AGN
US Market

Argenica Therapeutics Ltd (AGN) Financial Statements

Compare
12 Followers

Argenica Therapeutics Ltd Financial Overview

Argenica Therapeutics Ltd's market cap is currently AU$32.76M. The company's EPS TTM is AU$-0.047; its P/E ratio is -4.57; Argenica Therapeutics Ltd is scheduled to report earnings on August 28, 2025, and the estimated EPS forecast is AU$―. See an overview of income statement, balance sheet, and cash flow financials.
Dec 25Dec 24Dec 23Dec 22Dec 21
Income Statement
Total RevenueAU$ 3.21MAU$ 2.60MAU$ 0.00AU$ 259.10KAU$ 296.07K
Gross ProfitAU$ 3.21MAU$ 2.60MAU$ 1.75MAU$ 259.10KAU$ 296.07K
Operating IncomeAU$ -7.68MAU$ -5.67MAU$ -6.62MAU$ -4.09MAU$ -1.03M
EBITDAAU$ 0.00AU$ -1.90MAU$ -4.81MAU$ -4.09MAU$ -1.33M
Net IncomeAU$ -7.17MAU$ -5.48MAU$ -4.82MAU$ -4.09MAU$ -1.03M
Balance Sheet
Cash & Short-Term InvestmentsAU$ 10.56MAU$ 15.91MAU$ 9.34MAU$ 8.91MAU$ 7.14M
Total AssetsAU$ 11.04MAU$ 16.38MAU$ 9.54MAU$ 9.04MAU$ 7.27M
Total DebtAU$ 0.00AU$ 0.00AU$ 0.00AU$ 0.00AU$ 0.00
Net DebtAU$ -10.56MAU$ -15.91MAU$ -9.29MAU$ -8.91MAU$ -7.14M
Total LiabilitiesAU$ 3.80MAU$ 2.43MAU$ 1.87MAU$ 735.91KAU$ 425.72K
Stockholders' EquityAU$ 7.24MAU$ 13.95MAU$ 7.67MAU$ 8.31MAU$ 6.85M
Cash Flow
Free Cash FlowAU$ -5.70MAU$ -5.06MAU$ -3.30MAU$ -3.36MAU$ -1.05M
Operating Cash FlowAU$ -5.70MAU$ -5.06MAU$ -3.30MAU$ -3.36MAU$ -1.05M
Investing Cash FlowAU$ 0.00AU$ 50.00KAU$ -50.00KAU$ 0.00AU$ 0.00
Financing Cash FlowAU$ 346.90KAU$ 11.63MAU$ 3.73MAU$ 5.13MAU$ 7.85M
Currency in AUD

Argenica Therapeutics Ltd Earnings and Revenue History

Argenica Therapeutics Ltd Debt to Assets

Argenica Therapeutics Ltd Cash Flow

Argenica Therapeutics Ltd Forecast EPS vs Actual EPS